Ph. D. in physical chemistry from Royal Institute of Technology and Executive MBA from Stockholm University.
Former CEO of Modus Therapeutics. Prior to that Director, Corporate Development in Sobi. Responsible to build and lead the function Project & Portfolio Management in Biovitrum. Also Member of the Boards of PCI Biotech and Idogen.